HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series.

AbstractBACKGROUND:
Gingival enlargement (GE) is a frequent side effect that occurs in organ transplant recipients (OTR) after the administration of cyclosporin A (CsA). The availability of new drugs used to suppress graft rejection in OTR offers an opportunity to manage GE non-surgically. This preliminary case series aimed to analyze the effect of CsA withdrawal and its substitution by another immunosuppressant in OTR with severe GE.
METHODS:
Four organ transplant recipients who had received a liver or renal allograft were recruited for this study. All OTR had developed clinically severe CsA-induced GE. GE scores were assessed for each patient at baseline and at weeks 2, 4, 8, 12, 16, and 54 following conversion to tacrolimus. Scaling and root planing were initially performed and repeated monthly during the first 6 months. Careful polishing of the teeth was carried out once every 2 weeks until month 6 and then monthly until month 12. Hygiene instructions and reinforcement to optimize oral hygiene were maintained throughout the study.
RESULTS:
The four patients showed a rapid decrease in their gingival symptoms and in the size of the gingivae. This change was clinically evident 8 weeks after conversion to tacrolimus. One year later, all the patients experienced GE regression, although some anatomic irregularities persisted in the interdental papillae of one of the patients. No adverse effects from tacrolimus were observed during the study except in one patient who presented headaches.
CONCLUSION:
It seems that CsA withdrawal and its conversion to tacrolimus in organ transplant recipients who develop severe gingival enlargement, together with an extensive plaque control program, provide an effective means to control/eliminate gingival hyperplasia, with minimal risk of graft dysfunction.
AuthorsGonzalo Hernández, Lorenzo Arriba, María Cruz Frías, José Carlos de la Macorra, Juan Carlos de Vicente, Carlos Jiménez, Amado de Andrés, Enrique Moreno
JournalJournal of periodontology (J Periodontol) Vol. 74 Issue 12 Pg. 1816-23 (Dec 2003) ISSN: 0022-3492 [Print] United States
PMID14974825 (Publication Type: Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus
Topics
  • Adult
  • Analysis of Variance
  • Cyclosporine (adverse effects)
  • Female
  • Gingival Overgrowth (chemically induced, drug therapy)
  • Graft Rejection (prevention & control)
  • Humans
  • Immunosuppressive Agents (adverse effects, therapeutic use)
  • Kidney Transplantation (adverse effects)
  • Liver Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Pilot Projects
  • Tacrolimus (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: